PRNewsWire
21 May 2026, 19:33 UTC · 24w ago
Impact · against what's priced in
ADMA Biologics faces severe valuation risk as a law firm investigation formalizes existing fraud allegations and guidance withdrawals. Teladoc and Olin Corporation are also under investigation, introducing new legal uncertainty for both companies.
No priced-in read yet
What the story claims
4 claims · scored −1 bearish … +1 bullish
Culper Research alleged that ADMA Biologics engaged in a channel stuffing scheme and used an undisclosed related party distributor to fabricate growth.
So whatAllegations of financial fraud and artificial revenue inflation are severe catalysts for permanent valuation impairment.
More negative than 99% of claims this week
ADMA Biologics withdrew its long-term financial guidance on May 6, 2026, citing competitive dynamics in the U.S. plasma products market.
Continue reading
5 related stories
The company is facing a formal investigation into securities fraud following allegations of a channel stuffing scheme and the withdrawal of its long-term financial guidance.
Read from the article alone
No priced-in read yet
Pomerantz Law Firm has launched an investigation into potential securities fraud or unlawful business practices by Olin Corporation.
Read from the article alone
No priced-in read yet
Pomerantz Law Firm has launched an investigation into potential securities fraud or unlawful business practices by Teladoc Health.
Read from the article alone
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 97% of claims this week
Pomerantz LLP has launched an investigation into potential securities fraud and unlawful business practices by ADMA and its officers.
More negative than 90% of claims this week
Cantor Fitzgerald downgraded ADMA after the company failed to provide specific feedback addressing the claims in the Culper report.
More negative than 85% of claims this week
Which stocks this story touches
More negative than 98% of ticker scores this week
The company is facing a securities fraud investigation, allegations of channel stuffing, a broker downgrade, and the withdrawal of financial guidance.
More negative than 92% of ticker scores this week
The company is being investigated by Pomerantz Law Firm on behalf of its investors.
More negative than 92% of ticker scores this week
The company is being investigated by Pomerantz Law Firm on behalf of its investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1h ago
+54.3%
Price is moving against the score
$13.21 vs $8.56 close before publication (May 20) · not market-adjusted
ADMA chart →+45.2%
Price is moving against the score
$9.41 vs $6.48 close before publication (May 20) · not market-adjusted
TDOC chart →−31.4%
Price agrees with the score
$18.06 vs $26.31 close before publication (May 20) · not market-adjusted
OLN chart →
